Business Health & beauty Paid
WSE introduces Genomtec shares to trading on NewConnect
22:31
Genomtec, dealing with medical technology, specializing in isothermal amplification of nucleic acids, applicable both in clinical diagnostics at the place of patient care, and rapid genetic tests, after successful completion public offering and obtaining PLN 8 million is on the final straight before debuting on NewConnect. The Warsaw Stock Exchange has just passed a resolution to introduce Genomtec shares to the alternative trading system on the NewConnect market.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
